10165948001
Roche
RNA, MS2
from bacteriophage MS2
Synonym(s):
RNA, ribonucleic acid
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
biological source
bacteriophage MS2
Quality Level
form
solution
mol wt
~1200 kDa
packaging
pkg of 500 μL (10 A260 units)
manufacturer/tradename
Roche
technique(s)
RNA extraction: suitable
color
colorless
solubility
water: miscible
storage temp.
−20°C (−15°C to −25°C)
Related Categories
General description
RNA, from bacteriophage MS2 is composed of 3569 nucleotides. MS2 bacteriophage acts as a model system in studying molecular biology processes, such as viral RNA replication, process of translation and physiology of infected cells. MS2 RNA codes for three viral polypeptides namely, protein A, coat protein and RNA replicase complex. Protein A and coat protein make up the structure of MS2 virus.
Application
RNA, MS2 has been used:
- as a standard to assess RNA quantification methods
- in RNA extraction
- in single-tube, fluorescent PERT assay (STF-PERT) for accurate quantitation of different retrovirus types
- for studies which use natural RNA in a in vivo and in vitro protein-synthesizing system, initiation, elongation, and termination of polypeptide synthesis.
- for structural and functional studies.
- to stabilize RNA during cDNA synthesis
- to improve RNA yield during RNA extraction or isolation
Quality
Typical analysis: Free of protein and host nucleic acids according to current Quality Control procedures.
Sequence
Chain Length 3,569 nucleotides
Preparation Note
Working solution: Storage buffer: 10 mM Tris-HCl, 1 mM EDTA, pH 7.0.
Other Notes
For life science research only. Not for use in diagnostic procedures.
Storage Class Code
12 - Non Combustible Liquids
WGK
nwg
Flash Point(F)
No data available
Flash Point(C)
No data available
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Wellcome open research, 5, 181-181 (2020-12-09)
Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses PCR to detect viral RNA (vRNA) in respiratory samples. SARS-CoV-2 RNA has also been detected in other sample types, but there is limited understanding of the clinical or laboratory
Cancers, 13(17) (2021-09-11)
MicroRNAs (miRNAs) are short, non-coding RNAs involved in translation regulation. Dysregulation has been identified in cancer cells. miRNAs can be secreted and detectable in body fluids; therefore, they are potential liquid-biopsy biomarkers. The miR-371a-3 cluster members are an example, monitoring
Journal of assisted reproduction and genetics, 37(9), 2199-2209 (2020-07-19)
miRNAs have been suggested as biomarkers of embryo viability; however, findings from preliminary studies are divergent. Furthermore, the presence of other types of small RNA molecules remains to be investigated. The purpose of this study was to perform a comprehensive
Carcinogenesis, 37(10), 941-950 (2016-08-04)
Early detection of colorectal cancer is the main prerequisite for successful treatment and reduction of mortality. Circulating microRNAs were previously identified as promising diagnostic, prognostic and predictive biomarkers. The purpose of this study was to identify serum microRNAs enabling early
International journal of molecular sciences, 21(8) (2020-04-25)
There is evidence for the effects of platelet inhibition on innate immune activation. Circulating microRNAs (miRNAs) have been implicated as markers of platelet and leukocyte activation. In the present study, we assessed the effects of P2Y12 inhibitors on platelet and
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service